These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17964911)

  • 1. Prevention of diabetes development in those with the metabolic syndrome.
    Tupper T; Gopalakrishnan G
    Med Clin North Am; 2007 Nov; 91(6):1091-105, viii-ix. PubMed ID: 17964911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic options for the prevention of type 2 diabetes mellitus in the metabolic syndrome.
    Lukacova-Zib I; Gopalakrishnan G
    Mt Sinai J Med; 2010; 77(5):524-32. PubMed ID: 20960554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management issues in the metabolic syndrome.
    Deedwania PC; Gupta R
    J Assoc Physicians India; 2006 Oct; 54():797-810. PubMed ID: 17214277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and type 2 diabetes: can we stop the weight gain with diabetes?
    Joffe D; Yanagisawa RT
    Med Clin North Am; 2007 Nov; 91(6):1107-23, ix. PubMed ID: 17964912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?
    Bays H; Blonde L; Rosenson R
    Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):871-95. PubMed ID: 17173503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmet needs in controlling metabolic disease.
    Haffner SM
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S17-24. PubMed ID: 17934390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome.
    Erbas T
    Acta Diabetol; 2003 Dec; 40 Suppl 2():S401-4. PubMed ID: 14704875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome.
    Suzuki T; Homma S
    Med Clin North Am; 2007 Nov; 91(6):1211-23, x. PubMed ID: 17964917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends?
    Ballantyne CM
    Crit Pathw Cardiol; 2007 Jun; 6(2):41-5. PubMed ID: 17667863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversy in diagnosis and management of the metabolic syndrome.
    Brietzke SA
    Med Clin North Am; 2007 Nov; 91(6):1041-61, vii-viii. PubMed ID: 17964908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study.
    Ilanne-Parikka P; Eriksson JG; Lindström J; Peltonen M; Aunola S; Hämäläinen H; Keinänen-Kiukaanniemi S; Laakso M; Valle TT; Lahtela J; Uusitupa M; Tuomilehto J;
    Diabetes Care; 2008 Apr; 31(4):805-7. PubMed ID: 18184907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and strategies in managing cardiometabolic risk.
    Repas TB
    J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):S4-11. PubMed ID: 17784529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifestyle modifications for the prevention and treatment of cardiovascular disease: an evidence-based approach.
    Harris GD; White RD
    Mo Med; 2004; 101(3):222-6. PubMed ID: 15311577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonpharmacologic management of mixed dyslipidemia associated with diabetes mellitus and the metabolic syndrome: a review of the evidence.
    Stone NJ
    Am J Cardiol; 2008 Dec; 102(12A):14L-18L. PubMed ID: 19084085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome and cardiovascular disease: part 2.
    Jiamsripong P; Mookadam M; Alharthi MS; Khandheria BK; Mookadam F
    Prev Cardiol; 2008; 11(4):223-9. PubMed ID: 19476575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.
    Cannon CP
    Am J Cardiol; 2008 Dec; 102(12A):5L-9L. PubMed ID: 19084083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological interventions in the prevention of type 2 diabetes.
    Henness S
    Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):166-9. PubMed ID: 17940436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome: diabetes and cardiovascular disease.
    Gupta S; Gupta BM
    Indian Heart J; 2006; 58(2):149-52. PubMed ID: 18989060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of cardiac rehabilitation on coronary risk factors, inflammation, and the metabolic syndrome in obese coronary patients.
    Lavie CJ; Morshedi-Meibodi A; Milani RV
    J Cardiometab Syndr; 2008; 3(3):136-40. PubMed ID: 18983328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.